Delivery Order 75N95018G00019-75N95022F00001
Award Date
11/17/21
Potential Completion Date
6/30/25
Potential Value
$1.7M
Federal Agency
National Institute on Drug Abuse
Awardee
Sri International
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services, to SRI International, a non-profit research institute. The $3,698,818.25 contract is for non-clinical absorption, distribution, metabolism, and excretion (ADME) studies, with a period of performance from September 19, 2016 to September 18, 2021. This award does not have a small business set-aside. SRI International, as the prime...
This federal contract award, with a ceiling value of $1,927,163.66, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The contract was awarded to SRI International, a non-profit research and development organization, and is part of NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract, which is a Delivery Order under the PTNP Indefinite Delivery Vehicle (IDV), is for IND-enabling studies....
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to SRI International, a non-profit research and development organization. The contract is an administrative task order under the Pharmacology and Toxicology for Neurotherapeutics Program (PTNP) indefinite delivery vehicle (IDV). The total ceiling value of this award is $106,072.00, and the period of performance is from September 13, 2015 to September 12, 2016. The contract is a...
This is a definitive, cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the U.S. Department of Health and Human Services. The contract, valued at $11,883,375.62, was awarded on December 15, 2002 to Sri International, a non-profit research and development institute, for the purpose of de-obligating FY2006 funds. The contract has a period of performance through December 31, 2009 and is being performed in West Menlo Park, CA. Sri...
This is a $4,228,000.27 cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (a component of the U.S. Department of Health and Human Services) to the non-profit research institute SRI International. The contract is for investigational new toxicology studies for drugs to treat Alzheimer's disease and other aging-related diseases. The contract does not have a small business set-aside designation. SRI International is an experienced federal contractor and grantee,...
This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to SRI International, a large non-profit research and development institute. The contract, valued at $1,726,546.26, is for conducting safety and toxicology studies on cystine, a chemical compound, as part of NIDA's Toxicological Evaluation of Novel Ligands Program. The contract is a cost-plus-fixed-fee type and does not have a small business...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Cost Plus Fixed Fee delivery order contract to SRI International, a non-profit research and development institute. The $1,256,044.00 contract is for GLP (Good Laboratory Practice) interaction safety studies in rats and dogs, under an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. The contract is not set aside for any specific business type. SRI International...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to SRI International, a non-profit research and development institute. The contract is for $403,254.01 and is part of NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract is for "Pharmacokinetics and Toxicology Studies - Buckpitt LDT" and is a Cost Plus Fixed Fee delivery order. The contract does not have a set-aside designation. SRI International is...
This federal contract, awarded by the National Institute on Drug Abuse (NIDA) to SRI International, provides for the production and analysis of synthetic peptides and other drugs of abuse. The contract has a base period of performance from September 29, 2018 to September 28, 2019, with a total potential value of $1,449,873.34 over an anticipated 5-year period through September 28, 2023. The contract does not have a small business set-aside designation. SRI International is a non-profit...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to SRI International, a non-profit research and development institute. The contract, worth $138,512.00, is for acute toxicology testing of a radiotracer for cyclooxygenase-1 (COX-1) during the performance period of June 30, 2015 to June 29, 2016. This contract is not set aside for any particular business category. SRI International has...